St. Jude Medical, Inc. (STJ), a medical devices company, Thursday announced CE mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease or CAD. The system will be on display for the first time in Europe during EuroPCR.
The system offers twice the resolution for microscopic examination of disease inside the artery to assist with stent placement. The real-time, three-dimensional reconstruction offers a 360-degree panoramic view of the vessel, making it easier for physicians to visualize the area they are treating.
According to St. Jude Medical, it is the only company to provide these tools together in an integrated platform.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.